The U.S. Department of Justice has reportedly recently launched an antitrust investigation of UnitedHealth Group, which begs the question of whether the healthcare giant should be broken up. Experts have varying opinions.
Generic drugmakers Teva and Glenmark recently became the sixth and seventh drugmakers to resolve criminal charges as a result of the DOJ’s yearslong investigation into generic drug price fixing. The settlement agreement requires both companies to pay hefty fines as well as divest their drug lines for pravastatin, a widely used statin that lowers cholesterol.
Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.
There appears to be no slowdown of federal enforcement activity in the healthcare sector in the foreseeable future. Therefore, the DOJ's guidance to prosecutors is especially relevant to this industry and provides useful insights on ways to mitigate risks in the event of criminal enforcement activity.
A neighborhood pharmacy owner was the largest purchaser of oxycodone among retail pharmacies in the entire state of Pennsylvania by 2016 and pled guilty to charges of conspiracy and fraud.
The charges involve some of the first cases in the country involving fraudulent cardiovascular genetic testing, a “burgeoning scheme,” according to a news release from the DOJ.
The U.S. government brought the suit against Methodist Le Bonheur Healthcare and Methodist Healthcare Memphis Hospitals, accusing the hospital system of paying millions of dollars of kickbacks to West Clinic, P.C., a cancer center with sites across the Southeast.
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
In its earnings statement, the company disclosed that it received a civil investigative demand from the Department of Justice. Specifically, the agency was looking for information on Oak Street’s relationships with third-party marketing agents and transportation services.
The Department of Justice and the Department of Homeland Security subpoenaed the company for information related to its reporting of injuries, Peloton disclosed in an SEC filing on Friday. The company recalled its line of treadmills earlier this year after multiple reports of injuries and one death.
Spearheaded by the Departments of Justice, and Health and Human Services, efforts to investigate and prosecute healthcare fraud resulted in the government recovering billions, including about $2.1 billion for the Medicare Trust Funds.
The American Hospital Association is urging the Justice Department to thoroughly review UnitedHealth's intended acquisition of Change Healthcare. The transaction would reduce competition in the health IT arena and result in higher prices and lower quality of care, the hospital group says.
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
The investigation resulted in charges against more than 345 defendants for more than $6 billion in alleged fraud losses. Roughly $4.5 billion of that was connected to telemedicine, the Department of Justice said.
Practice Fusion will pay $145 million to resolve criminal and civil allegations that it received kickbacks from an unnamed pharmaceutical company in exchange for building a clinical decision support system that could influence opioid prescriptions. The system generated more than 230 million alerts between 2016 and 2019, according to court documents.
Alongside the payment, which resolves the civil aspect of the probe from the DOJ and a number of states that UHS incorrectly billed Medicare and Medicaid programs, the government has dropped the criminal investigation against the company.
While the shareholder vote is a major milestone, the deal still needs to get the approval of an additional 22 state regulators.
The Louisville-based insurer broke its long-standing no comment policy, citing "significant investor speculation and persistent market rumors."